# Riboflavin-UVA Induced Collagen Crosslinking Treatment for Corneal Ectasia

> **NCT01123057** · NA · UNKNOWN · sponsor: **Singapore National Eye Centre** · enrollment: 30 (estimated)

## Conditions studied

- Corneal Ectasia

## Interventions

- **PROCEDURE:** riboflavin-induced collagen cross-linking treatment
- **DEVICE:** Riboflavin-UVA induced collagen cross-linking treatment for corneal ectasia

## Key facts

- **NCT ID:** NCT01123057
- **Lead sponsor:** Singapore National Eye Centre
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-08
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01123057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01123057, "Riboflavin-UVA Induced Collagen Crosslinking Treatment for Corneal Ectasia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01123057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*